Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 17c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.22), $0.17 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance
- BMO Capital on U.S. boat registrations: macroeconomic conditions continue to pressure retail demand
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
